Welcome to our dedicated page for Celestica SEC filings (Ticker: CLS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Celestica Inc. filings document operating results, governance actions, capital-structure matters, and shareholder communications for a Canadian issuer with common shares registered under CLS on the New York Stock Exchange.
Recent disclosures include Form 8-K reports for quarterly and annual financial results, Regulation FD communications, board and committee transitions, annual meeting records, material-event reporting, and share repurchase authorization. The definitive proxy statement covers director elections, executive compensation, shareholder voting procedures, governance policies, and related proxy matters for Celestica’s public-company oversight.
Celestica Inc. director reports acquisition of additional director share units. A board member of Celestica Inc. (CLS) filed a Form 4 disclosing that on 12/31/2025 they acquired 267 director share units. These units carry no exercise price and represent the right to receive an equal number of common shares, or an equivalent cash amount, when the holder stops serving Celestica as a director, consultant or other service provider, at the company’s discretion. Following this transaction, the reporting person beneficially owns 1,116 derivative securities (director share units) on a direct basis.
Celestica Inc. reported an insider equity award for one of its directors. On 12/31/2025, the director acquired 170 director share units at a price of $0, reported as a derivative security. After this transaction, the director beneficially owned 170 director share units on a direct basis. Each director share unit represents a contingent right to receive one common share of Celestica, or an equivalent value in cash at the company’s discretion, when the holder ceases to serve the issuer as a director, consultant, or other service provider.
Celestica IncDecember 31, 2025, the reporting person was granted 237 restricted share units (RSUs), each representing a contingent right to receive one common share or an equivalent cash amount at the holder's election. The RSUs were reported as derivative securities beneficially owned in direct form.
The award vests over time, with one-third of the 237 RSUs vesting annually over three years on the anniversary of the grant date. This type of grant is a standard form of non-cash compensation that aligns a director’s interests with those of shareholders by linking part of their compensation to the company’s share performance.
Celestica Inc. reported an equity compensation transaction by one of its directors on a Form 4. On 12/31/2025, the director acquired 127 director share units, listed as derivative securities with a price of $0, reflecting a grant rather than an open-market purchase.
After this transaction, the director beneficially owns 531 director share units, held directly. According to the disclosure, each director share unit represents a contingent right to receive one common share of Celestica or an equivalent value in cash, at the company’s discretion, when the holder stops serving as a director, consultant or other service provider. This filing highlights ongoing alignment of director compensation with shareholder interests through share-based awards.
Celestica Inc. director reports grant of restricted share units
A director of Celestica Inc. (CLS) filed a Form 4 disclosing an equity award dated December 31, 2025. The reporting person received 129 restricted share units (RSUs), each representing a contingent right to receive one common share or an equivalent cash value at the holder's election.
According to the disclosure, one-third of the 129 RSUs vests annually over three years on the anniversary of the grant date. This filing reflects routine equity-based compensation for a board member rather than an open‑market purchase or sale of Celestica shares.
Celestica Inc. director reports receipt of equity-based compensation. A company director filed a Form 4 showing the acquisition of 118 director share units on 12/31/2025. These units are derivative securities that each represent a contingent right to receive one common share or an equivalent cash value, at Celestica’s discretion, when the holder stops serving as a director, consultant or other service provider.
Following this transaction, the director beneficially owns 495 director share units in total, held directly. The transaction was coded as an acquisition at a stated price of $0, indicating it is part of the director’s compensation rather than an open-market purchase.
Celestica Inc. director reports equity award activity and share withholding. A director of Celestica Inc. (CLS) reported several transactions dated 12/31/2025. The filing shows 4,266 common shares acquired at a stated price of $0 and 2,049 common shares disposed of at $299.45 to satisfy tax withholding on vested restricted share units (RSUs), leaving 18,547 common shares held directly.
Derivative tables show RSUs being exercised into common shares and director share units being credited. RSU grants made on December 31 of 2022, 2023, and 2024 each vest in three equal annual installments, and each RSU represents a contingent right to receive one common share or cash at the holder’s election. Director share units each represent a contingent right to receive one common share or cash when the holder ceases serving the company.
Celestica Inc. announced that Dr. Luis Müller plans to resign from its Board of Directors, including his roles as Chair of the Audit Committee and member of other board committees, effective at the conclusion of the regularly scheduled meeting on January 28, 2026. The company states that his decision is for personal reasons related to other professional commitments and not due to any disagreement with Celestica regarding its operations, policies, or practices.
To ensure continuity in oversight, the Board has appointed current director Amar Maletira to become Chair of the Audit Committee effective upon Dr. Müller’s resignation. Maletira brings over 25 years of public company business, strategic, and finance leadership experience, including multiple Chief Financial Officer roles, and has been determined by the Board to possess the financial expertise appropriate for this key governance position.
Celestica Inc. (CLS) Chief Legal Officer filed an amended Form 4 to report an equity award. On February 4, 2025, the reporting person received 2,317 restricted share units (RSUs), each representing a right to one common share or cash of equal value at the holder's election. These RSUs vest in two equal installments on February 4, 2026 and February 4, 2027. The amendment corrects the earliest transaction date and adds this previously omitted RSU grant, while all other information from the original filing remains unchanged.
Celestica Inc. Chief Financial Officer insider activity shows routine equity compensation events reported on a Form 4. On 12/01/2025, the CFO acquired 20,408 common shares through the vesting and settlement of previously granted restricted share units at an exercise price of $0. On the same date, 10,925 common shares were disposed of at $344.41 per share to cover tax withholding obligations arising from the RSU vesting, leaving the reporting person with 9,483 common shares held directly.
The derivative table shows 20,408 restricted share units exercised into common shares, reducing the reporting person’s RSU balance to zero for that grant. The filing notes that each RSU represents a contingent right to receive one common share or an equivalent cash amount, and that the original grant of 61,224 RSUs from 01/31/2023 vests in three installments over a three-year period.